MedTrace Logo

AED/Statin Interaction Study

NCT00627575 · Status: COMPLETED · Phase: PHASE1 · Type: INTERVENTIONAL · Enrollment: 119

Last updated 2017-08-04

No results posted yet for this study

Summary

This study will evaluate the amount of the cholesterol-lowering drug atorvastatin available in the bloodstream, when taken together with the anti-seizure drugs lamotrigine or phenytoin.

Conditions

Interventions

DRUG

lamotrigine

Lamotrigine tablets will be available in 25, 50, 100 and 200 mg dose strength.

DRUG

atorvastatin

Atorvastatin will available as 40 mg tablets.

DRUG

phenytoin

Phenytoin will available as 100 mg capsules.

Sponsors & Collaborators

Principal Investigators

  • GSK Clinical Trials · GlaxoSmithKline

Study Design

Allocation
NON_RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
55 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2008-02-04
Primary Completion
2008-09-12
Completion
2008-09-12

Countries

  • United States

Study Locations

More Related Trials

Entities

Drugs
Diseases
Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00627575 on ClinicalTrials.gov